We report here that overexpression of the tuberous sclerosis-1 (TSC1) gene product hamartin results in the inhibition of growth, as well as changes in cell morphology. Growth inhibition was associated with an increase in the endogenous level of the product of the tuberous sclerosis-2 (TSC2) gene, tuberin. As overexpression of tuberin inhibits cell growth, and hamartin is known to bind tuberin, these results suggested that hamartin stabilizes tuberin and this contributes to the inhibition of cell growth. Indeed, transient transfection of TSC1 increased the endogenous level of tuberin, and transient co-transfection of TSC1 with TSC2 resulted in higher tuberin levels. The stabilization was explained by the ®nding that tuberin is highly ubiquitinated in cells, while the fraction of tuberin that is bound to hamartin is not ubiquitinated. Co-expression of tuberin stabilized hamartin, which is weakly ubiquitinated, in transiently transfected cells. The amino-terminal two-thirds of tuberin was responsible for its ubiquitination and for stabilization of hamartin. A mutant of tuberin from a patient missense mutation of TSC2 was also highly ubiquitinated, and was unable to stabilize hamartin. We conclude that hamartin is a growth inhibitory protein whose biological eect is likely dependent on its interaction with tuberin. Oncogene (2000) 19, 6306 ± 6316.
Introduction
Tuberous sclerosis complex (TSC), a member of the phakomatoses, is a dominantly inherited human disease aecting approximately one in 6000 individuals (Gomez et al., 1999; Wiederholt et al., 1985) . TSC patients develop a variety of lesions aecting the nervous system, kidneys, skin, heart and lungs, with varying clinical course and phenotypic severity (Roach et al., 1998) . The hallmark TSC lesion (from which it gets its name) is the benign hamartoma (tuber) of the cerebral cortex, which can be associated with mental retardation and seizures. The cortical tubers, as well as the complications from the kidney lesions, often result in signi®cant morbidity and mortality (Gomez et al., 1999) . TSC patients also show a low but signi®cant increase in the rates of malignancies, including those of the kidney and brain. Thus TSC, like the other phakomatoses, can be considered to be a hereditary cancer syndrome, suggesting that the gene(s) which give rise to TSC may act as tumor suppressors (Knudson, 1993) .
Studies of the genetics of TSC have revealed that this disorder displays several interesting properties. Both sporadic and inherited cases have been documented, with approximately two-thirds of the cases falling into the former class; the relatively high proportion of cases with new mutations may re¯ect reduced genetic ®tness in aected individuals (Gomez et al., 1999) . Another interesting feature is that TSC displays genetic heterogeneity, and has been linked to two dierent loci. Both susceptibility genes have been identi®ed and characterized: the TSC1 gene lies at 9q34 and encodes a 135 kDa protein of 1164 amino acids, designated hamartin, while the TSC2 gene maps to 16p13 and encodes a 180 kDa protein (tuberin) of 1784 amino acids (European Chromosome 16 Tuberous Sclerosis Consortium, 1993; TSC1 Consortium, 1997) . Recent studies of benign lesions from TSC patients demonstrated evidence for functional inactivation of both copies of TSC1 or of TSC2 in the aected cells (Green et al., 1994; Henske et al., 1995 Henske et al., , 1996 . Thus, like other tumor suppressors, pathogenic TSC1 and TSC2 mutations are recessive at the level of the aected cells, although the disease is transmitted as a dominant trait (Knudson, 1993) . Further evidence of the tumor suppressor function of TSC2 comes from the Eker rat strain, in which 100% of heterozygotes bearing a germline mutation in the rat homologue of TSC2 develop renal cell tumors in which the normal allele is also inactivated (Kobayashi et al., 1995; Yeung et al., 1994) . In addition, we and others have shown that TSC2 acts directly to inhibit cell growth in vitro when introduced into cells lacking tuberin expression, or when overexpressed in cells with two normal copies of TSC2 (Jin et al., 1996; Orimoto et al., 1996) .
The properties of tuberin and hamartin, as well as their expression and localization in cells and tissues, have been studied through the development and application of speci®c antisera (Gutmann et al., 2000; Nellist et al., 1999; Plank et al., 1998 Plank et al., , 1999 Wienecke et al., 1996 Wienecke et al., , 1997 . Tuberin, which contains a Cterminal domain with homology to known GTPase activating proteins (GAPs) for the small GTPase Rap1, has been shown to possess GAP activity for Rap1 and for another small GTPase, Rab5 (Wienecke et al., 1995; Xiao et al., 1997) . Hamartin, which has predicted coiled-coil regions but no known enzymatic function, was recently shown to interact with members of the ezrin/radixin/moesin (ERM) family and to cause changes in adhesion and actin organization, likely via activation of the small GTPase Rho (Lamb et al., 2000) .
The similarity of phenotype induced by inactivation of TSC1 or TSC2 suggests that these proteins may aect the same pathways or processes. Although the exact nature of how this may occur remains unclear, recent studies have found that hamartin and tuberin associate to form a complex in intact cells (Nellist et al., 1999; Plank et al., 1998; van Slegtenhorst et al., 1998) . This result suggests that there is a temporal/ spatial link between the TSC1 and TSC2 products that may play a role in their tumor suppressor functions. Here we provide direct evidence that TSC1, like TSC2, can suppress the growth of cultured cells. Furthermore, we ®nd that the hamartin-induced growth inhibition correlates with an increase in tuberin levels, and that this eect is also seen in transient transfection experiments. These results suggest a role for the hamartin-tuberin complex in regulating protein stability; therefore, we investigated the regulation of turnover of these proteins. We report here that tuberin is a heavily ubiquitinated protein whose turnover is dependent on the proteasome, and that binding of hamartin to tuberin protects it from ubiquitination. Hamartin was also found to be ubiquitinated, though much less robustly, and to be stabilized by coexpression of tuberin. These results suggest a novel mechanism of tumor suppression involving complex formation and reciprocal stabilization of two tumor suppressor products, resulting in the sustained transmission of growth-suppressive signals.
Results

Overexpression of TSC1 in rat fibroblasts inhibits growth and causes morphological changes
To investigate the eects of overexpression of hamartin, we transfected the Rat-2 immortalized ®broblast line with a full-length cDNA clone of human TSC1 linked to the neomycin resistance marker. Following selection with G418, we established several clonal lines and carried out immunoblotting to analyse them for hamartin expression. Approximately twothirds of the resistant clones showed evidence of hamartin overexpression (data not shown). Among the resistant clones we chose two for further analysis, along with one clone selected following transfection with insertless vector (Figure 1a ). Compared to the parental line or the vector clone (E1-3), the TSC1 clones (C4-3 and D1-10) expressed signi®cantly more of the 135 kDa hamartin protein ( Figure 1a , top panel), though some of this dierence may result from more ecient recognition of human hamartin, against which the antiserum was raised, than of the endogenous (rat) protein. As hamartin is known to bind tuberin and form a complex in cells, we also examined the level of endogenous 180 kDa tuberin in these clones ( Figure 1a , bottom panel), and found that in the hamartin-overexpressing clones there was a consistently elevated level of endogenous tuberin.
As the overexpression of other tumor suppressor genes, including TSC2, has been shown to inhibit cell growth, we examined the growth of the hamartinoverexpressing clones under various conditions ( Figure  1b) . We observed that both clones C4-3 and D1-10 grew signi®cantly more slowly than the vector control clone under low serum (0.5%; top panel), intermediate (2%; middle), or high serum (10%, bottom). Though the eect was more pronounced in serum-limiting conditions, we conclude that consistent with its role as a tumor suppressor, overexpression of TSC1 inhibits cell growth in vitro. In addition to being inhibited in their growth, we noted an alteration in the morphology of the clones overexpressing TSC1 (Figure 1c ). While the vector control clone E1-3 displayed a¯at, nonrefractile,`cobblestone' appearance that was identical to that of the parental Rat-2 line, the C4-3 and D1-10 clones exhibited an elongated morphology, characterized by increased refractility, that was visible at both low and high cell density (Figure 1c) . At high density, there was also a clear increase in the spacing between cells, consistent with their lower saturation density as documented in Figure 1b . Finally, we saw a consistent increase in the number of non-adherent, highly refractile cells, and detached cells¯oating in the cultures of the C4-3 and D1-10 clones ( Figure 1c and data not shown). These changes in morphology may re¯ect alterations in the actin cytoskeleton, as hamartin was recently shown to bind ERM family members and activate the Rho GTPase and actin ®ber assembly (Lamb et al., 2000) .
Conditional overexpression of genes represents an additional method for the analysis of their function, with the advantage that the same clone of cells is analyzed in the induced or uninduced state. Therefore, we employed the pRetro-O system, in which removal of tetracycline (Tet) causes de-repression of transcription from a promoter which then drives expression of TSC1. We transfected this construct into a strain of rat embryo ®broblasts (REF) from an embryo derived from a cross between Eker rat heterozygotes, containing two intact copies of TSC2(+/+). A clone of REF transfected with insertless vector (designated clone A2) served as a control. We found that the pRetro-O-TSC1 clone, designated B14, signi®cantly overexpressed hamartin even before induction, although the level did increase further after removal of Tet ( Figure  2a , top panel). Thus this expression system proved to be leaky for TSC1. In addition, we noted an increase in the level of endogenous tuberin in the B14 clone that correlated with TSC1 overexpression, compared to the A2 clone (Figure 2a, middle panel) . No change was observed in the control blot for the p120 GAP protein (Figure 2a, bottom) . When the growth of these clones was analysed, we found a signi®cant reduction in the growth of the uninduced B14 cells as compared to A2 (Figure 2b ). The reduction in growth was somewhat greater following removal of Tet from the B14 culture.
We also observed similar changes in the morphology of the B14, TSC1-overexpressing REF as we had seen in the Rat-2 clones (data not shown). Thus in two independent cell lines, using two dierent expression systems, we found that overexpression of TSC1 was associated with increased endogenous tuberin, and resulted in growth inhibition and morphological changes. , and two Rat-2 derived clones from cells transfected with pEFP2-TSC1 were grown in 10% serum until con¯uent, then lysed. Portions of each lysate containing 50 mg of cell protein were analysed by SDS ± PAGE and immunoblotting with anity-puri®ed rabbit antibodies against the hamartin (top), or rabbit antiserum against the C-terminus of the tuberin (bottom). X=blank lane. As a control, 10 mg of a lysate prepared from Cos-7 transfected with PEFP2-TSC1 plus pSG5-TSC2 was run in the right lane of each panel. Blots were visualized using enhanced chemiluminescence (ECL) as described in Materials and methods. Migration of the 135 kDa hamartin and the 180 kDa tuberin is shown at right, while that of molecular size standards (M r 610
73
) is indicated at left. (b) Control clone E1-3 and TSC1-overexpressing clones C4-3 and D1-10 were plated in duplicate sets of 60 mm wells at 5610 4 cells/ well, and grown for the indicated times in 0.5% (top), 2.0% (middle), or 10% (bottom) fetal bovine serum, then trypsinized and counted. (c) The control and TSC1-overexpressing Rat-2 clones were plated in 100 mm plates at 5610 4 (low density) or 3610 5 (high density) cells/plate and grown for 7 days, then subjected to phase ± contrast photomicroscopy. Original magni®cation was 1006
Transient transfection of TSC1 stabilizes tuberin and prevents its ubiquitination
The experiments described above suggested that increasing the intracellular level of hamartin led to a coordinate increase in the level of tuberin. Therefore, we carried out transient transfection of cells with TSC1 using a highly ecient electroporation system. At various times following transfection, the cells were lysed, and the level of tuberin was quanti®ed by immunoblotting with anti-tuberin antibodies, and scanning of the 125 I-labeled bands (Table 1) . We found that in both REF and human kidney (293) cells, transfection of TSC1 resulted in a signi®cant (1.6 ± 2.8-fold) increase in the level of endogenous tuberin after about 20 h, with a fall-o by 30 ± 40 h, when the level of exogenous hamartin was also decreasing (Table 1 ; data not shown). As an additional means to address these questions, we turned to transient co-transfection of TSC1 and TSC2 in monkey Cos-7 cells, which provide the advantage of high copy number overexpression of plasmids such as pSG5 and pEFP2, allowing for better biochemical analyses. We found that co-transfection of pEFP2-TSC1 with pSG5-TSC2 resulted in a twofold increase in the level of tuberin, as compared to insertless pEFP2 plus pSG5-TSC2 ( Figure  3 ). The increased levels of endogenous and exogenous tuberin observed in transiently TSC1-transfected cells are consistent with the results of the experiments described above employing stable and conditional overexpression systems for TSC1.
The consistent observation of increased tuberin levels in cells with elevated hamartin led us to investigate the possible mechanisms underlying this phenomenon. Northern blotting of the Rat-2 TSC1-overexpressing clones revealed that the level of TSC2 mRNA was not signi®cantly elevated, suggesting that the higher tuberin levels were a result of protein metabolism (data not shown). One cellular system for regulating the level of (7) for 24 h, then lysed. Portions of each lysate containing 50 mg of cell protein were analysed by SDS ± PAGE and immunoblotting with anity-puri®ed rabbit antibodies against hamartin (top), rabbit antiserum against the C-terminus of tuberin (middle), or rabbit antiserum against p120 GAP (bottom). As controls, 50 mg of lysate from the parental REF {TSC2 (+/+)}; Eker rat-derived REF from embryos lacking tuberin expression {TSC2 (7/7)}; human embryonic kidney cells (293); or human cervical carcinoma cells (HeLa) were included.
Blots were visualized using ECL as described in Materials and methods. Migration of the 135 kDa hamartin, the 180 kDa tuberin, and p120
GAP is shown at right, while that of molecular size standards (M r 610
) is indicated at left. (b) The control (A2) or TSC1-overexpressing (B14) cells were plated in duplicate sets at 5610 4 cells/60 mm dish, and grown with or without Tet for the indicated times, then trypsinized and counted. Signi®cant growth inhibition was observed for the B14 clone both in the presence and absence of Tet, correlating with the leaky overexpression of hamartin in this system Cell lysates were prepared and analysed at the indicated times post-transfection; c Ratio of tuberin in pEFP2-TSC1-tranfected versus insertless pEFP2-transfected cultures proteins involves proteolysis via ubiquitin-mediated degradation. In this system, speci®c addition of multiple copies of a 76-amino acid ubiquitin tag to lysine residues on a protein results in the protein being targeted for degradation in the proteasome complex, which contains a variety of proteases (Ciechanover, 1998 (Ciechanover, , 2000 . To investigate whether the regulation of tuberin levels may involve the ubiquitin pathway, we cotransfected a plasmid encoding the in¯uenza virus hemaglutinin (HA) epitope-tagged ubiquitin together with TSC1, TSC1+TSC2, or TSC2 alone into Cos-7 cells. Following 48 h, the cells were lysed, and the lysates subjected to immunoprecipitation with anti-HA antibodies. The immunoprecipitates were then analysed by immunoblotting with anti-tuberin antiserum ( Figure  4) . We observed that HA-immunoprecipitates from cells transfected with TSC2 contained a very large amount of tuberin, consistent with this protein being ubiquitinated. Interestingly, HA-immunoprecipitates from cells cotransfected with TSC1+TSC2 contained much less tuberin. This was true despite the fact that these cells actually contain more total tuberin ( Figure  3) , suggesting that the presence of exogenous hamartin in the cells resulted in protection of tuberin from ubiquitination and degradation. In a preliminary examination of the sequences within tuberin required for ubiquitination, we also probed HA-immunoprecipitates prepared from Cos-7 transfected with deletion mutants of TSC2 encoding amino acids 1 ± 1387 (TSC-N) or amino acids 931 ± 1784 (TSC-C), as well as a missense mutant (N1658K) derived from a TSC patient (TSC2*) (Figure 4 ). The mutation which gave rise to TSC2* is apparently pathogenic and resides within the conserved GAP domain at the C-terminus of tuberin. The 1 ± 1387 product (Tub-N; 150 kDa) was prominent in the HA-immunoprecipitates, while the 931 ± 1784 (Tub-C; 90 kDa) product was only very weakly detected. Interestingly, the product of the N1658K missense mutant was detected at high levels in the HAimmunoprecipitates, suggesting that the protein en- Figure 4 Tuberin is a ubiquitinated protein. Cos-7 were transfected with a plasmid encoding an in¯uenza virus hemaglutinin epitope-tagged form of ubiquitin (HA-Ub) as well the indicated plasmids (as in Figure 3 ) encoding TSC1; TSC2; a construct (TSC2-N) encoding a 150 kDa N-terminal fragment of tuberin (1-1387; Tub-N); a construct (TSC2-C) encoding a 90 kDa C-terminal fragment of tuberin (931-1874; Tub-C); or a patient-derived missense mutant of TSC2 (N1658K) designated TSC2*. After 48 h, the cells were lysed and portions of the cell lysates containing 300 mg of cell protein were subjected to immunoprecipitation with 5 mg mouse monoclonal anti-HA antibodies. The immunoprecipitates were analysed by SDS ± PAGE, followed by immunoblotting with rabbit anti-tuberin serum raised against amino acids 1165 ± 1393, which recognizes all of these tuberin constructs. Blots were visualized using ECL as described in the Materials and methods. Migration of the180 kDa tuberin, Tub-N and Tub-C is shown at right, while that of molecular size standards (M r 610
) is indicated at left ) is indicated at left coded by this mutant was at least as highly ubiquitinated as the wild-type protein (see below).
To verify these results, we prepared lysates from the same sets of co-transfections and subjected them to immunoprecipitation with anti-tuberin or anti-hamartin sera, then carried out immunoblotting with anti-HA antibodies ( Figure 5, top panel) or anti-tuberin antibodies ( Figure 5, bottom panel) . Consistent with the results obtained in Figure 4 , we observed HAimmunoreactivity in the anti-tuberin immunoprecipitates prepared from TSC2-transfected Cos-7. The immunoreactivity appeared as a broad smear extending from the normal position of tuberin to the top of the gel. The TSC2* product was at least as highly ubiquitinated as the wild-type protein, based on a comparison of the reactivities in the top and bottom panels. Again consistent with the results of Figure 4 , signi®cant ubiquitination of the TSC-N product was detected, while there was no HA-immunoreactivity in the immunoprecipitates from the TSC-C transfected cells ( Figure 5 ). Upon longer exposure of the autoradiogram, we also detected a low level of HAhamartin in the hamartin immunoprecipitates from cells transfected with TSC1 alone (see also Figure 9 ). Most signi®cantly, there was no detectable HAimmunoreactive tuberin in the anti-hamartin immunoprecipitates prepared from TSC1+TSC2-transfected cells, even though there was an abundant level of tuberin in the immunoprecipitate ( Figure 5 , bottom panel). We conclude that tuberin is a highly ubiquitinated protein, and that binding of hamartin to tuberin blocks the ubiquitination of tuberin.
To verify that the proteasome plays a role in the degradation of tuberin, we analysed the ability of a biochemical inhibitor of one of the proteases, calpain inhibitor 1 (C.I.), to stabilize tuberin in TSC1+TSC2-transfected Cos-7 (Figure 6 ). Following treatment with or without 10 mM C.I. for 3, 6, or 13 h, signi®cantly more tuberin was present in the lysates of the transfected cells that had been treated with inhibitor than in lysates from untreated cells. Similar results were detected in cells transfected with TSC2 alone (data not shown). Note that treatment of TSC1+TSC2-transfected cells with C.I. did not prevent the formation of slower migrating species of tuberin, which likely re¯ect the sequential addition of Figure 5 Binding of hamartin to tuberin prevents its ubiquitination. Cos-7 were transfected with HA-Ub together with the indicated plasmids and lysed as in Figure 4 , and immunoprecipitations were carried out using 5 mg puri®ed anti-hamartin antibody (left two lanes) or 20 ml rabbit anti-tuberin (1165 ± 1393) serum (right four lanes). In the top panel, the immunoprecipitates were analysed by SDS ± PAGE and immunoblotting with mouse monoclonal anti-HA antibodies, while in the bottom panel the immunoprecipitates were probed with rabbit anti-tuberin (1165 ± 1393) serum. Migration of the 135 kDa hamartin, the 180 kDa tuberin, the 150 kDa Tub-N, and the 90 kDa Tub-C is shown at right, while that of molecular size standards (M r 610
) is indicated at left. Tuberin that is co-immunoprecipitated with hamartin lacks detectable ubiquitination (left lane in each panel) Figure 6 Treatment of cells with the proteasomal protease inhibitor calpain inhibitor 1 (C.I.) prevents degradation of tuberin. Cos-7 were transfected with pEFP2-TSC1 and pSG5-TSC2 and after 48 h the cells were either left untreated (7) or treated (+) with 10 mM C.I. for 3, 6, or 13 h as indicated, and lysed. Portions of each lysate containing 50 mg of cell protein were analysed by SDS ± PAGE and immunoblotting with rabbit antiserum against the C-terminus of tuberin. The immunoblot was visualized using ECL as described in Materials and methods. M=lane in which molecular size standards were run. Migration of the 180 kDa tuberin is shown at right (note the presence of multiple bands), while that of molecular size standards (M r 610
) is indicated at left. Arrows denote the migration of multiple tuberin-reactive bands ubiquitin molecules to uncomplexed tuberin that precedes degradation in the proteasome (Ciechanover et al., 2000) (Figure 6 ).
Hamartin is stabilized by co-expression with tuberin and is ubiquitinated
During the course of these experiments, we also noted that cotransfection of TSC1+TSC2 in Cos-7 resulted in the accumulation of more hamartin than when TSC1 was transfected alone. An example of such an experiment is shown in Figure 7 . Here, co-transfection of TSC1 with full-length TSC2, or with TSC-N, resulted in the accumulation of signi®cantly more hamartin at 48 h, while co-transfection with TSC-C had no in¯uence on the level of hamartin (Figure 7 , top panel). Blotting with anti-tuberin antibodies con®rmed the expression of each of these constructs (Figure 7, bottom panel) . Similar results were obtained in other cell types, including REF and 293 (data not shown). These results suggested that tuberin can in¯uence the stability of hamartin in a reciprocal relationship to that described above. To further explore this phenomenon, we carried out co-transfection of TSC1 with TSC2 constructs and let the cells grow for 48 h, then pulsed the cells with cycloheximide for various times to block protein synthesis, prepared lysates and carried out immunoblotting with antihamartin antibodies (Figure 8 ). In samples prepared from Cos-7 transfected with TSC1+Vector, TSC1+TSC2-C, or TSC1+TSC2*, there was a timedependent formation of slower-migrating forms of hamartin, and a decrease in the overall level of hamartin. In contrast, in the TSC1+TSC2 and TSC1+TSC2-N samples, there was little if any degradation of hamartin, and very little of the more slowly-migrating forms. We conclude that tuberin, or its N-terminal two-thirds, can stabilize hamartin following transient co-transfection of TSC1 and TSC2 in Cos-7.
Based on these results, we investigated whether hamartin may also be subjected to ubiquitin-mediated degradation. Therefore, we co-transfected Cos-7 with TSC1 and the HA-Ub plasmid, and prepared lysates following 48 h (Figure 9) . Part of the lysate was used to prepare immunoprecipitates with anti-HA antibodies, and these immunoprecipitates, along with a portion of the original lysate, were analysed by immunoblotting with anti-hamartin antibodies. Although the signal was much weaker than that seen for tuberin (Figure 4 ), we were able to detect a band corresponding to hamartin in the HA-immunoprecipitates (Figure 9 ), indicating that under these conditions, hamartin can undergo ubiquitination. We also observed that anti-hamartin immunoprecipitates prepared from these lysates contained HA-immunoreactive material corresponding to the molecular weight of hamartin (data not shown). In addition, we observed that in Cos-7 cells transfected with TSC1, treatment with C.I. had a modest stabilizing eect on the level of hamartin, while a second proteasome inhibitor, clastolactacystin-b-lactone, caused a dose-dependent reduction in the formation of the slower-migrating forms of hamartin (data not shown). We conclude that under these conditions, tuberin is able to stabilize hamartin, and hamartin is weakly ubiquitinated and may be subject to proteasome-mediated degradation.
Discussion
Here we have demonstrated that overexpression of the TSC1 product hamartin in rodent cell lines inhibits their growth, and induces changes in the morphology of the cells. This is consistent with the role of TSC1 as Figure 7 Transient co-transfection of TSC2 with TSC1 increases the level of exogenously-expressed hamartin. Cos-7 cells were plated and transfected with pEFP2-TSC1 plus insertless pSG5 (left lane); pEFP2-TSC1 plus pSG5-TSC2 (second lane); pEFP2-TSC1 plus pSG5-TSC2-C (third lane); or pEFP2-TSC1 plus pSG5-TSC2-N (right lane). After 48 h, the cells were lysed and portions of the cell lysates containing 50 mg of cell protein were analysed by SDS ± PAGE, then subjected to immunoblotting with anti-anity-puri®ed rabbit antibodies against hamartin (top panel), or with rabbit anti-tuberin (1165 ± 1393) serum (bottom panel). The immunoblot was visualized using ECL as described in Materials and methods. Migration of the 135 kDa hamartin, the 180 kDa tuberin, the 150 kDa Tub-N, and the 90 kDa Tub-C is shown at right, while that of molecular size standards (M r 610 73 ) is indicated at left. Co-expression of full-length tuberin or the Nterminal construct enhances the expression of hamartin a tumor suppressor, for numerous other tumor suppressors, including the retinoblastoma susceptibility gene (RB), the neuro®bromatosis 1 gene (NF1) and the p53 gene have also been shown to suppress cell growth (Huang et al., 1988; Johnson et al., 1994; Michalovitz et al., 1990) . These experiments represent a direct con®rmation of the growth-inhibitory activity of TSC1, and also provide a potentially useful biological assay for the analysis of hamartin function. The data also showed that stable overexpression of hamartin induced an elevation of the level of cellular tuberin, the TSC2 product, and transient transfections veri®ed that elevated levels of hamartin could increase the overall level of either endogenous or exogenous tuberin. Taken together with the fact that we and others have previously demonstrated that overexpression of TSC2 can inhibit cell growth and tumorigenicity (Jin et al., 1996; Orimoto et al., 1996) , these results suggest that boosting the cellular content of the hamartin-tuberin complex enhances the growth suppressive activity of these tumor suppressor proteins. In such a model, the complexed forms of hamartin and tuberin would represent the most active forms of the proteins. An alternative possibility is that hamartin and tuberin act independently as growth-suppressors, and mutual stabilization of the proteins as demonstrated here increases their individual negative signaling. In such a complex-independent model, activities of the proteins which are not known to require the other partner, such as the demonstrated GTPase activating (GAP) activity of tuberin toward Rap1 and Rab5 (Wienecke et al., 1995; Xiao et al., 1997) , and the role of hamartin as a binding partner for the ERM proteins and activator of the Rho GTPase (Lamb et al., 2000) may cause inhibition of growth.
Another important aspect of this work is the demonstration that tuberin is strongly ubiquitinated and subject to proteasome-dependent degradation. In our analyses, all of the hamartin-bound tuberin was non-ubiquitinated, suggesting that the elevated levels of tuberin in cells overexpressing hamartin re¯ect reduced turnover of tuberin in the proteasome. This interpretation was also supported by the fact that treatment of cells with calpain inhibitor increased the level of tuberin. Many cellular proteins have been found to be subject to ubiquitin-mediated degradation (reviewed in Ciechanover, 1998; Ciechanover et al., 2000) , including cyclins (Koepp et al., 1999) , regulators of transcription factors (Palombella et al., 1994) , protooncoproteins (Nielsen et al., 1997; Treier et al., 1994) , and the products of the tumor suppressor genes p53 and NF1 (Maki et al., 1996; K Cichowski, personal communication) . One common feature of these proteins is the presence of a short sequence known as a PEST element (a region rich in the amino acids proline, glutamate, serine and threonine) (Ciechanover et al., 2000) . Although this is a loose de®nition, an examination of the sequence of tuberin reveals that there are a number of potential PEST sequences, including the regions from 650 ± 674 (16/25`PEST' amino acids) and 831 ± 854 (11/24). We have shown that the primary site(s) for ubiquitination of tuberin lie within the ®rst 1387 amino acids, and likely in the ®rst 930 amino acids, for while the Tub-N (1 ± 1387) protein was eciently ubiquitinated, very little ubiquitination was observed for the Tub-C (931 ± 1784) protein.
Interestingly the patient mutant bearing a single missense substitution (N1658K) appeared to be enhanced in its ubiquitination. This could result from enhanced ligation of ubiquitin to an improperly folded mutant protein, or from the presence of the unnatural lysine residue produced by the mutation as a potential novel site for ubiquitination, which occurs via ligation to lysine residues.
In addition to the clear eects on the stabilization of tuberin by hamartin, we made the unexpected observation that in transient co-transfection experiments, overexpression of tuberin also resulted in the accumulation of higher levels of hamartin. This was surprising in light of the fact that cells lacking tuberin expression, such as TSC2 (7/7) REF derived from the Eker rat strain, express similar levels of hamartin as cells that Figure 8 Cycloheximide treatment time course demonstrates stabilization of hamartin by tuberin or its N-terminus. Cos-7 cells were transfected with TSC1 plus empty vector; TSC1 plus TSC2; TSC1 plus TSC2-C; TSC1 plus TSC2-N; or TSC1 plus TSC2*, as indicated. After 48 h, cultures of transfected cells were lysed (7) or treated with cycloheximide (100 mg/ml) for the indicated times and lysed. Portions of the lysates containing 50 mg of cell protein were analysed by SDS ± PAGE and subjected to immunoblotting with anti-anity-puri®ed antibodies against hamartin. The immunoblot was visualized using ECL as described in Materials and methods. Migration of molecular size standards (M r 610
73
) is indicated at left. At right, arrows denote the migration of multiple hamartin-reactive bands extending up from the expected 135 kDa. Co-expression of hamartin with full-length tuberin or the Nterminal construct, but not the C-terminus or the patient missense mutant, prevents formation of the slower-migrating forms of hamartin, and enhances the expression of hamartin relative to the TSC1 plus vector samples are wild-type at TSC2 ( (Plank et al., 1998) ; see also Figure 2a ). Nevertheless, we found that tuberin can stabilize hamartin and prevent the formation of the more slowly-migrating forms of the protein that (based on pulse-chase experiments) precede proteolysis. Only the N-terminal two-thirds of tuberin, where interaction sites for hamartin have been mapped (van Slegtenhorst et al., 1998) , was required for this eect. In addition, we were able to detect ubiquitination of hamartin, although the level of ubiquitination was much less robust than was seen for tuberin, calling into question whether or not it is a physiologically relevant observation. Potential PEST sequences in hamartin were identi®ed, including the regions from 570 ± 592 and 1017 ± 1052. In addition, speci®c inhibitors of proteasomal proteases enhanced the stability of hamartin, consistent with its degradation through this pathway. These results suggest the existence of a reciprocal stabilization mechanism for the products of these two tumor suppressor genes, a novel phenomenon in tumor cell biology.
Although the data presented here represent a unique situation involving two tumor suppressors, other examples exist in which protein ± protein interactions aect the ubiquitination and stability of important regulators of cell growth. The inhibitor of the transcription factor NF-kB, designated IkBa, contains a PEST sequence that can undergo phosphorylation at two serines following extracellular stimulation (Palombella et al., 1994) . This is followed by ubiquitindependent degradation of IkBa, resulting in the unmasking of a nuclear translocation signal for NFkB. A second example is provided by the interaction of the oncoprotein b-catenin with the adenomatous polyposis coli (APC) tumor suppressor product (Ciechanover et al., 2000) . Here, stimulation of cells leads to activation of a transcription complex containing b-catenin. When the APC product associates with b-catenin, the complex accelerates the ubiquitination and degradation of b-catenin, preventing it from forming the active transcription complex A third example is provided by the p53 tumor suppressor, whose product can be targeted for ubiquitinationmediated degradation (Maki et al., 1996) . The cellular proto-oncoprotein Mdm2, which is overexpressed in a variety of tumors, binds to p53 and accelerates its degradation through the ubiquitin pathway, thus leading to abrogation of the cell cycle checkpoint monitored by p53 (Haupt et al., 1997; Kubbutat et al., 1997) . As p53 positively regulates the expression of Mdm2, a negative feedback loop based on ubiquitinmediated degradation acts to regulate the level of p53 activity.
The model of a reciprocal stabilization mechanism for the products of the TSC genes is supported, albeit indirectly, by the results of other recent studies. First, hamartin and tuberin display a very similar pattern of expression among dierent tissues (Gutmann et al., 2000; Plank et al., 1999; Wienecke et al., 1997) ; these patterns were described in one report as`almost identical' (Plank et al., 1999) . Such a distribution would be expected if the active forms of these proteins are represented by the pools of each present as a complex, and also if reciprocal stabilization of hamartin and tuberin were important in the physiological regulation of the levels of these proteins in vivo. Second, a recent study of brain, kidney and heart lesions of TSC patients described the coordinate loss of expression of both tuberin and hamartin in cells of these lesions, suggesting mutation of one TSC gene may result in a secondary eect on the expression of the other gene product (Mizuguchi et al., 2000) . A similar observation has been made in analyses of skin lesions from TSC patients, in which 67% of lesions with reduced expression of hamartin or tuberin also lacked expression of the other protein (R Wienecke, unpublished results). These observations are consistent with the presence of both partners contributing to enhanced levels of the other, and with the loss of one partner resulting in decreased stability of the other.
The studies described here have shed light on the biological function of the TSC1 gene, and also provide new insights into the mechanisms regulating hamartin and tuberin. However, they do not resolve the ultimate question of how the inactivation of TSC1 or TSC2 results in the uncontrolled growth and dierentiation that leads to the development of the characteristic TSC Figure 9 Hamartin is ubiquitinated in transiently-transfected Cos-7 cells. Cos-7 cells were transfected with pEFP2-TSC1 plus the HA-Ub plasmid. After 48 h, the cells were lysed, and one portion of the lysate containing 50 mg of cell protein was analysed by SDS ± PAGE (left lane). Alternatively, portions of the lysate containing 300 mg of cell protein were subjected to immunoprecipitation with 1 or 5 mg of anti-HA antibody, as indicated (right lanes). M=lane in which molecular size standards were run. The gel was analysed by immunoblotting with anity-puri®ed rabbit antibodies raised against hamartin, then visualized using ECL as described in Materials and methods. Migration of the 135 kDa hamartin product is shown at right, while that of molecular size standards (M r 610
) is indicated at left lesions. The clari®cation of these issues may ultimately depend on the use of animal models to ascertain the biochemical function of hamartin and tuberin in growth regulation and dierentiation. A recent report describing a Drosophila homologue of TSC2 with a cell cycle regulatory function, as well as the existence of a TSC1 homologue (Ito and Rubin, 1999) , may provide future insights, especially in light of the fact that other studies suggest a role for tuberin in the regulation of the cell cycle (Soucek et al., 1997 (Soucek et al., , 1998 ).
Materials and methods
Plasmids
A full-length clone of human TSC1 was removed from the vector pGEM-T Easy (Promega Biotech) by NotI digestion and transferred to the plasmid pEFP2 (Qian et al., 1998) , or pRetro-O (Clontech Inc.). A full-length clone of human TSC2, lacking the alternatively-spliced exon 31, and therefore corresponding with the sequence reported in Consortium (1993), was removed from the expression vector pSG5 (Green et al., 1988) by BamHI digestion and transferred to the multiple cloning site of pBluescript SK-(Stratagene Corp.). To produce the TSC-C mutant, digestion of pBluescript-TSC2 was carried out with SpeI, which removed the region up to amino acid 931, and ligated to a sticky-ended, doublestranded oligonucleotide encoding a Kozak sequence and inframe initiator methionine. This construct was then removed as a NotI fragment and transferred to pSG5. To produce the TSC-N mutant, digestion of pBluescript-TSC2 was carried out with Bsu36 I and KpnI, which removed all sequences from amino acid 1387 to the 3' end. This was then ligated to a sticky-ended, double-stranded oligonucleotide encoding an in-frame termination codon. This construct was then removed as a NotI fragment and transferred to pSG5. The TSC2* patient mutant, encoding a missense mutation (N to K) at amino acid 1658 of the sequence in Consortium (1993) was expressed in pSG5. The HA-Ub plasmid was a kind gift of Dr Silvio Gutkind, National Institute of Dental Research.
Cell culture and transfections
Cells were grown in Dulbecco's modi®ed Eagle medium (D-MEM) with antibiotics and 10% (v/v) fetal bovine serum. To isolate stable Rat-2 clones, transfection of pEFP2 or PEFP2-TSC1 was carried out using calcium phosphate as described previously (Velu et al., 1989) , and selection was carried out with 600 mg/ml G418 for 14 days. Individual G418-resistant colonies were then cloned and analysed. To isolate cell clones conditionally expressing TSC1, REF were transfected with pRetro-O or pRetro-O-TSC1 using lipofectamine (Life Technologies, Inc.) according to the manufacturer's instructions. The transfected cells were grown in the continuous presence of 2 mg/ml tetracycline and were subjected to selection in 1 mg/ml puromycin (Sigma) for 14 days, after which individual colonies were cloned and analysed. For the experiments in Table 1 , we carried out electroporation using the BTX T820 electroporator system (Genetronics, Inc.) according to the manufacturer's instructions. 2610 7 cells were electroporated with 30 mg DNA, then replated, and lysed at the indicated times. Control transfections with a lacZ plasmid indicated that under these conditions up to 80 per cent of the cells take-up and express the exogenous plasmid (data not shown). All Cos-7 transfections were carried out with lipofectamine, using 2610 6 cells/100 mm plate and 10 mg of total DNA; cells were lysed after 48 h.
Antisera
For detection of hamartin, rabbits were injected with a hexahistidine conjugated recombinant fragment of human hamartin corresponding to amino acids 748 ± 957, which was expressed in bacteria and puri®ed using nickel-agarose (Qiagen Corp.). Speci®c antibodies were puri®ed from the sera of immunoresponsive rabbits using anity chromatography against the same puri®ed recombinant protein. The anti-tuberin antisera directed against the C-terminus (amino acids 1387 ± 1784) (Wienecke et al., 1995) or against amino acids 1165 ± 1393 were described previously. Anti-HA mouse monoclonal antibody was obtained from BABCO Inc. The rabbit anti-p120 GAP serum B4F8 was obtained from Santa Cruz Biotechnology.
Cell lysis, immunoprecipitations and immunoblotting
For immunoblotting, cells were lysed in lysis buer (20 mM Tris-HCl, pH 7.4; 100 mM NaCl; 5 mM MgCl 2 ; 1% Nonidet P-40; 0.5% sodium deoxycholate; 16 mg per ml aprotinin; 10 mg per ml leupeptin; 1 mM PMSF; 1 mM Na 3 VO 4 ; 100 mM NaF; 10 mM sodium pyrophosphate). Lysates were clari®ed by microcentrifugation at 10 0006g for 10 min at 48C, and frozen at 7708C. The protein concentration of an aliquot from each lysate was determined using the bicinchoninic acid assay (Pierce). Fifty mg protein from each lysate was electrophoresed in an 8% polyacrylamide gel, and electroblotted onto an Immobilon membrane (Millipore). For the experiments in Figures 4, 5 and 7, which combined immunoprecipitation and immunoblotting, the cells were lysed in C-type lysis buer (CLB) (20 mM Tris-HCl, pH 7.5; 150 mM NaCl; 5 mM MgCl 2 ; 2 mM EDTA; 10% glycerol {v/v}; 1% Nonidet P-40; 16 mg per ml aprotinin; 10 mg per ml leupeptin; 1 mM PMSF; 1 mM Na 3 VO 4 ; 100 mM NaF; 10 mM sodium pyrophosphate). The lysates were clari®ed, the protein content was determined, and portions of each lysate containing 300 mg protein were subjected to immunoprecipitation with 1 mg or 5 mg of puri®ed antibody (as indicated), or 20 ml of crude rabbit serum, and protein-A sepharose (Amersham Pharmacia Biotech) for 2 h at 48C. The immunoprecipitates were washed twice with CLB, analysed on a 8% polyacrylamide gel, and transferred to a ®lter.
For all immunoblotting, the membranes were blocked overnight at 48C, incubated with a 1 : 1000 dilution of crude antiserum or 1 mg/ml puri®ed antibody for 2 h at room temperature, and washed. Detection of bound antibodies was carried out (for all experiments except those in Table 1 and Figure 3 ) with the ECL Plus enhanced chemiluminescence (ECL) system (Amersham Pharmacia Biotech). For the experiments in Table 1 and Figure 3 
